Action Packet - Workforce Development & Tourism Subcommittee (February 4, 2020)
Summary
An action packet of the Workforce Development & Tourism Subcommittee for its meeting on Tuesday, February 4, 2020, 9:00 AM, with Rene Plasencia as Chair. The committee meeting report lists HB 1139 as Favorable (Yeas: 12, Nays: 1), PCS for HB 1271 as Favorable (Yeas: 12, Nays: 1) and HB 1297 as Favorable With Committee Substitute (Yeas: 9, Nays: 5), with Amendment 264657 Adopted. It states the meeting was reported out on Tuesday, February 04, 2020 at 12:04PM. The vote sheet for HB 1139 (Regional Rural Development Grants) is followed by a list of appearances in support of that bill.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Action Packet - Workforce Development & Tourism Subcommittee (February 4, 2020).”
Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2020-02-04-3015-workforce-development-tourism-subcommittee-action-pack-bb2193f326/
, SHA-256 0ef862c847324ba315cf549fd7e73b2c8a73e752ff61b210317093430dbe7305.Full text
Workforce Development & Tourism
Subcommittee
Tuesday, February 4, 2020
9:00 AM -11:00 AM
12 HOB
Action Packet
Jose Oliva Rene Plasencia
Speaker Chair
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
Summary:
Workforce Development & Tourism Subcommittee
Tuesday February 04, 2020 09:00 am
HB 1139 Favorable Yeas: 12 Nays: 1
HB 1253 Favorable Yeas: 13 Nays: O
PCS for HB 1271 Favorable Yeas: 12 Nays: 1
HB 1297 Favorable With Committee Substitute Yeas: 9 Nays: 5
Amendment 264657 Adopted
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 1 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
Attendance:
Present Absent Excused
Rene Plasencia (Chair) X
Loranne Ausley X
Kamia Brown X
Dan Daley X
Tracie Davis X
Chip LaMarca X
Cindy Polo X
Spencer Roach X
Ana Maria Rodriguez X
Anthony Rodriguez X
Rick Roth X
Anthony Sabatini X
Jason Shoaf X
Tyler Sirois X
Jayer Williamson X
Totals: 14 0 1
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 2 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1139: Regional Rural Development Grants
0 Favorable
Yea Nay No Vote Absentee Absentee
Yea Nay
Loranne Ausley X
Kamia Brown X
Dan Daley X
Tracie Davis X
Chip LaMarca X
Cindy Polo X
Spencer Roach X
Ana Maria Rodriguez X
Anthony Rodriguez X
Rick Roth X
Anthony Sabatini X
Jason Shoaf X
Tyler Sirois X
Jayer Williamson X
Rene Plasencia (Chair) X
Total Yeas: 12 Total Nays: 1
Appearances:
Regional Rural Development Grants
Natalie Fausel (Lobbyist) (Lobbyist Appearance Form Submitted) - Waive In Support
Palm Beach County
201 W Park Avenue Suite 100
Tallahassee, FL
Phone: 561-317-0889
Regional Rural Development Grants
Tiffany Garling (General Public) - Waive In Support
Jackson County Chamber of Commerce
4318 Lafayette Street
Marianna, FL 32446
Phone: 850-482-8060
Regional Rural Development Grants
Darrick McGhee, Sr. (Lobbyist) (Lobbyist Appearance Form Submitted) - Waive In Support
Florida's Great Northwest
P.O. Box 10805
Tallahassee, FL
Phone: 850- 224-1900
Regional Rural Development Grants
Richard Williams (General Public) - Waive In Support
Opportunity Florida
4636 Highway 90 East, Suite K
Marianna, FL 32446
Phone: 850-557-2441
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 3 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1139: Regional Rural Development Grants (continued)
Appearances: (continued)
Regional Rural Development Grants
Carolyn Johnson (Lobbyist) - Waive In Support
Florida Chamber of Commerce
Policy Director
136 S Bronough St.
Tallahassee, FL
Phone: 521-1200
Regional Rural Development Grants
Adam Basford (Lobbyist) - Waive In Support
Florida Farm Bureau
Director, Legislative Affairs
310 w. College AVe
Tallahassee, FL 32301
Phone: 222-2557
Regional Rural Development Grants
Nicholas Alvarez (Lobbyist) (State Employee) - Waive In Support
Department of Economic Opportunity
Director of Legislative Affairs
107 E. Madison Street
Tallahassee, FL 32399
Phone: 850-245-7370
Regional Rural Development Grants
Beth Cicchetti (Lobbyist) - Waive In Support
Florida Economic Development Council
Executive Director
3551 Blairstone Rd. Ste 105-138
Tallahassee, FL 32301
Regional Rural Development Grants
Antonio Jefferson - Waive In Support
Florida Rural Economic Dev. Assoc.
Board Member
Gretna, FL
Phone: 850-519-0681
Regional Rural Development Grants
Chis Doolin (Lobbyist) - Proponent
Small County Coalition
Consultant
1118-B Thomasville Rd
Tallahassee, FL 32303
Phone: 850-508-5492
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 4 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1139: Regional Rural Development Grants (continued)
Appearances: (continued)
Regional Rural Development Grants
Roy Baker - Waive In Support
Jackson County Chamber of Commerce
4318 Lafayette Street
Marianna, FL 32446
Phone: 850-482-8060
Regional Rural Development Grants
B.D. Jogerst (Lobbyist) - Waive In Support
Associated Industries of Florida
516 N. Adams
Tallahassee, FL
Phone: 850-491-8552
Regional Rural Development Grants
Jeff Hendry - Waive In Support
North Florida Economic Development Partnership
Executive Director
Phone: 850-443-7103
Regional Rural Development Grants
Laura Youmans (Lobbyist) - Waive In Support
Florida Association of Counties
Legislative Counsel
100 S. Monroe St.
Tallahassee, FL 32301
Phone: 294-1838
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 5 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1253: Employer Contributions
0 Favorable
Yea Nay No Vote Absentee Absentee
Yea Nay
Loranne Ausley X
Kamia Brown X
Dan Daley X
Tracie Davis X
Chip LaMarca X
Cindy Polo X
Spencer Roach X
Ana Maria Rodriguez X
Anthony Rodriguez X
Rick Roth X
Anthony Sabatini X
Jason Shoaf X
Tyler Sirois X
Jayer Williamson X
Rene Plasencia (Chair) X
Total Yeas: 13 Total Nays: 0
Appearances:
Employer Contributions
Nicholas Alvarez (Lobbyist) (State Employee) - Waive In Support
Department of Economic Opportunity
Director of Legislative Affairs
107 E. Madison Street
Tallahassee, FL 32399
Phone: 850-245-7370
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 6 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
PCS for HB 1271: State Economic Development Entities
0 Favorable
Yea Nay No Vote Absentee Absentee
Yea Nay
Loranne Ausley X
Kamia Brown X
Dan Daley X
Tracie Davis X
Chip LaMarca X
Cindy Polo X
Spencer Roach X
Ana Maria Rodriguez X
Anthony Rodriguez X
Rick Roth X
Anthony Sabatini X
Jason Shoaf X
Tyler Sirois X
Jayer Williamson X
Rene Plasencia (Chair) X
Total Yeas: 12 Total Nays: 1
Appearances:
State Economic Development Entities
Nicholas Alvarez (Lobbyist) (State Employee) - Waive In Support
Department of Economic Opportunity
Director of Legislative Affairs
107 E. Madison Street
Tallahassee, FL 32399
Phone: 850-245-7370
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 7 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1297 : Drug-free Workplaces
0 Favorable With Committee Substitute
Yea Nay No Vote Absentee Absentee
Yea Nay
Loranne Ausley X
Kamia Brown X
Dan Daley X
Tracie Davis X
Chip LaMarca X
Cindy Polo X
Spencer Roach X
Ana Maria Rodriguez X
Anthony Rodriguez X
Rick Roth X
Anthony Sabatini X
Jason Shoaf X
Tyler Sirois X
Jayer Williamson X
Rene Plasencia (Chair) X
Total Yeas: 9 Total Nays: 5
HB 1297 Amendments
Amendment 264657
[!]Adopted
Appearances:
Drug-free Workplaces
Robbie Suggs - Waive In Support
VDX
CEO
P.O. Box 504
Branford, FL 32008
Phone: 386-867-1023
Drug-free Workplaces
Tabitha Burress (General Public) - Information Only
Florida Cannabis Action Network
4320 Randall Blvd
Naples, FL 34120
Phone: 2392722257
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 8 of 9
COMMITTEE MEETING REPORT
Workforce Development & Tourism Subcommittee
2/4/2020 9:00AM
Location: 12 HOB
HB 1297 : Drug-free Workplaces (continued)
Appearances: (continued)
Drug-free Workplaces
RJ Myers (Lobbyist) - Waive In Support
Save Our Society
Lobbyist
113 E. College Ave.
Tallahassee, FL 32301
Phone: 850-933-0883
Committee meeting was reported out: Tuesday, February 04, 2020 12:04PM
Print Date: 2/4/2020 12:04 pm Leagis ® Page 9 of 9
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED ~ (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/0 OBJECTION (Y/N)
FAILED TO ADOPT (Y/N)
WITHDRAWN (Y/N)
OTHER
1 Committee/Subcommittee hearing bill: Workforce Development &
2 Tourism Subcommittee
3 Representative Robinson offered the following:
4
5 Amendment (with title amendment)
6 Remove everything after the enacting clause and insert:
7 Section 1. Present subsections (13) through (17) of section
8 112.0455, Florida Statutes, are redesignated as subsections (14)
9 through (18), respectively, a new subsection (13) is added to
10 that section, and paragraph (b) of subsection (6) and paragraph
11 (a) of present subsection (15) are amended, to read:
12 112.0455 Drug-Free Workplace Act.-
13 (6) NOTICE TO EMPLOYEES.-
14 (b) Prior to testing, all employees and job applicants for
15 employment shall be given a written policy statement from the
16 employer which contains:
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 1 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
17 1. A general statement of the employer's policy on
18 employee drug use, which shall identify:
19 a. The types of testing an employee or job applicant may
20 be required to submit to, including reasonable suspicion or
21 other basis; and
22 b. The actions the employer may take against an employee
23 or job applicant on the basis of a positive confirmed drug test
24 result.
25 2. A statement advising the employee or job applicant of
26 the existence of this section.
27 3. A general statement concerning confidentiality.
28 4. Procedures for employees and job applicants to
:9 confidentially report the use of prescription or nonprescription
30 medications both befdre and after being tested. Additionally,
31 employees and job applicants shall receive notice of the most
32 common medications by brand name or common name, as applicable,
33 as well as by chemical name, which may alter or affect a drug
34 test. A list of such medications shall be developed by the
35 Agency for Health Care Administration.
36 5. The consequences of refusing to submit to a drug test.
37 6. Names, addresses, and telephone numbers of employee
38 assistance programs and local alcohol and drug rehabilitation
39 programs.
40 7. A statement that an employee or job applicant who
41 receives a positive confirmed drug test result may contest or
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 2 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
42 explain the result to the employer within 5 working days after
43 written notification of the positive test result. If an employee
44 or job applicant's explanation or challenge is unsatisfactory to
45 the employer, the person may contest the drug test result as
46 provided by subsections J..1..21 -f-±-4-t and J.1...§l -f±-§-t.
47 8. A statement informing the employee or job applicant of
48 his or her responsibility to notify the laboratory of any
49 administrative or civil actions brought pursuant to this
50 section.
51 9. A list of all drugs for which the employer will test,
52 described by brand names or common names, as applicable, as well
53 as by chemical names.
4 10. A statement regarding any applicable collective
55 bargaining agreement or contract and the right to appeal to the
56 Public Employees Relations Commission.
57 11. A statement notifying employees and job applicants of
58 their right to consult the testing laboratory for technical
59 information regarding prescription and nonprescription
60 medication.
61 (13) DRUG-TESTING STANDARDS; SAMPLE VALIDITY
62 PRESCREENING.-Before a drug-testing facility licensed under part
63 II of chapter 408 may perform any drug-screening test on a urine
64 specimen collected in this state, prescreening tests must be
65 performed to determine the validity of the specimen. The
66 prescreening tests must be capable of detecting, or detecting
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 3 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
67 and defeating, novel or emerging urine drug-testing subversion
68 technologies as described in this subsection.
69 (a) The drug-testing facility shall use urine sample
70 validity screening tests that meet all of the following
71 criteria:
72 1. A urine sample validity screening test for creatinine
73 must use a 20 mg/dL cutoff concentration and must have minimal
74 interferences from bilirubin and blood in the urine. The urine
75 sample validity screening test must be able to discriminate
76 between a creatinine level from an unadulterated urine sample
77 and a creatinine level arising from overhydration or creatine or
78 protein loading.
9 2. A urine sample validity screening test for oxidants
80 must be able to detect the presence or effects of oxidant
81 adulterants up to 6 days after sample collection, under the
82 sample storage conditions outlined in the laboratory standards
83 guideline adopted by rule by the Agency for Health Care
84 Administration, and after any sample transport that is routinely
85 involved.
86 3. Urine sample validity screening tests must be able to
87 detect synthetic or freeze-dried urine substituted for the
88 donor's urine for drug testing.
89 4. Urine sample validity screening tests must be validated
90 for the detection of all of the additional adulterant classes
91 represented by glutaraldehyde, salt, heavy metals, cationic
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 4 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
92 detergents, protease, strong alkaline buffers, and strong acidic
93 buffers. The detection limits of these classes must be at a
94 sufficient level to detect a nonphysiologic sample or
95 interference with enzyme immunoassay drug screening tests.
96 (b) The drug-testing facility may use only urine sample
97 validity screening tests that have undergone validation studies
98 conducted by the manufacturer to document the product's
99 conformance to the requirements of this subsection.
100 (c) A drug-testing facility may rely on urine sample
101 validity screening tests to determine if confirmation testing is
102 required for any urine sample that has been deemed invalid for
103 drug screening.
4 (d) Urine specimens collected in this state may not be
105 sent for drug screening tests to a drug-testing facility located
106 outside of this state unless such drug-testing facility complies
107 with all requirements of this subsection.
108 (e) The Agency for Health Care Administration shall adopt
109 rules necessary for the implementation and enforcement of this
110 subsection.
111 Jl...§l_-8--§-t NONDISCIPLINE REMEDIES.-
112 (a) Any person alleging a violation of the provisions of
113 this section, that is not remediable by the commission or an
114 arbitrator pursuant to subsection J.1.21 -f-±-4+, must institute a
115 civil action for injunctive relief or damages, or both, in a
116 court of competent jurisdiction within 180 days of the alleged
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 5 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
117 violation, or be barred from obtaining the following relief.
118 Relief is limited to:
119 1. An order restraining the continued violation of this
120 section.
121 2. An award of the costs of litigation, expert witness
122 fees, reasonable attorney attorney's fees, and noneconomic
123 damages provided that damages shall be limited to the recovery
124 of damages directly resulting from injury or loss caused by each
125 violation of this section.
126 Section 2. Present subsections (9) through (15) of section
127 440.102, Florida Statutes, are redesignated as subsections (10)
128 through (16), respectively, a new subsection (9) is added to
9 that section, and paragraphs (c), (e), and (q) of subsection
130 (1), paragraph (a) of subsection (3), paragraphs (b) through
131 (h), (j), (k), and (1) of subsection (5), subsection (6),
132 paragraph (a) of subsection (7), and paragraphs (b) and (c) of
133 present subsection (9) of that section are amended, to read:
134 440.102 Drug-free workplace program requirements.-The
135 following provisions apply to a drug-free workplace program
136 implemented pursuant to law or to rules adopted by the Agency
137 for Health Care Administration:
138 (1) DEFINITIONS.-Except where the context otherwise
139 requires, as used in this act:
140 ( c) "Drug" means any form of alcohol, as defined in s.
141 322.01(2), including a distilled spirit, wine, a malt beverage,
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 6 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
142 or an intoxicating preparation; any controlled substance
143 identified under Schedule I, Schedule II, Schedule III, Schedule
144 IV, or Schedule V of s. 893.03; any controlled substance
145 identified under Schedule I, Schedule II, Schedule III, Schedule
146 IV, or Schedule V of the Controlled Substances Act, 21 U.S.C. s.
147 812(c) liquor; an amphetamine; a cannabinoid; cocaine;
148 phencyclidine (PCP); a hallucinogen; methaqualone; an opiate; a
149 barbiturate; a benzodiazepine; a synthetic narcotic; a designer
150 ~ ; or a metabolite of any of the substances listed in this
151 paragraph. An employer may test an individual for any or all e-f.
152 such drugs.
153 (e) "Drug test" or "test" means any chemical, biological,
,4 or physical instrumental analysis administered7 by a laboratory
155 certified by the United States Department of Health and Human
156 Services or licensed by the Agency for Health Care
157 Administration7 for the purpose of determining the presence or
158 absence of a drug or its metabolites. In the case of testing for
159 the presence of alcohol, the test must be conducted in
160 accordance with the United States Department of Transportation
161 alcohol testing procedures authorized under 49 C.F.R. part 40,
162 subparts J through M.
163 (q) "Specimen" means tissue, hair, or a product of the
164 human body capable of revealing the presence of drugs or their
165 metabolites, as approved by the United States Food and Drug
166 AdministrationL er the Agency for Health Care AdministrationL
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 7 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
167 the United States Department of Health and Human Services, or
168 the United States Department of Transportation.
169 (3) NOTICE TO EMPLOYEES AND JOB APPLICANTS.-
170 (a) One time only, before prior to testing, an employer
171 shall give all employees and job applicants for employment a
172 written policy statement that which contains:
173 1. A general statement of the employer's policy on
174 employee drug use, which must identify:
175 a. The types of drug testing an employee or job applicant
176 may be required to submit to, including reasonable-suspicion
177 drug testing or drug testing conducted on any other basis.
178 b. The actions the employer may take against an employee
9 or job applicant on the basis of a positive confirmed drug test
180 result.
181 2. A statement advising the employee or job applicant of
182 the existence of this section.
183 3. A general statement concerning confidentiality.
184 4. Procedures for employees and job applicants to
185 confidentially report to a medical review officer the use of
186 prescription or nonprescription medications to a medical review
187 officer both before and after being tested.
188 5. A list of the most common medications, by brand name or
189 common name, as applicable, as well as by chemical name, which
190 may alter or affect a drug test. A list of such medications as
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 8 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
191 developed by the Agency for Health Care Administration shall be
192 available to employers through the department.
193 6. The consequences of refusing to submit to a drug test.
194 7. A representative sampling of names, addresses, and
195 telephone numbers of employee assistance programs and local drug
196 rehabilitation programs.
197 8. A statement that an employee or job applicant who
198 receives a positive confirmed test result may contest or explain
199 the result to the medical review officer within 5 working days
200 after receiving written notification of the test result; that if
201 an employee's or job applicant's explanation or challenge is
202 unsatisfactory to the medical review officer, the medical review
13 officer shall report a positive test result back to the
204 employer; and that a person may contest the drug test result
205 pursuant to law or to rules adopted by the Agency for Health
206 Care Administration.
207 9. A statement informing the employee or job applicant of
208 his or her responsibility to notify the laboratory of any
209 administrative or civil action brought pursuant to this section.
210 10. A list of all drugs for which the employer will test,
211 described by brand name or common name, as applicable, as well
212 as by chemical name.
213 11. A statement regarding any applicable collective
214 bargaining agreement or contract and the right to appeal to the
215 Public Employees Relations Commission or applicable court.
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 9 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
216 12. A statement notifying employees and job applicants of
217 their right to consult with a medical review officer for
218 technical information regarding prescription or nonprescription
219 medication.
220 (5) PROCEDURES AND EMPLOYEE PROTECTION.-All specimen
221 collection and testing for drugs under this section shall be
222 performed in accordance with the following procedures:
223 (b) Specimen collection must be documented, and the
224 documentation procedures shall include the7
225 -l-. labeling of specimen containers so as to reasonably
226 preclude the likelihood of erroneous identification of test
227 results. For saliva or breath alcohol testing, a specimen
8 container is not required if the specimen is not being
229 transported to a laboratory for analysis
230 2. A form for the employee or job applicant to provide any
231 information he or she considers relevant to the test, including
232 identification of currently or recently used prescription or
233 nonprescription medication or other relevant medical
234 information. The form must provide notice of the most common
235 medications by brand name or common name, as applicable, as well
236 as by chemical name, which may alter or affect a drug test. The
237 providing of information shall not preclude the administration
238 of the drug test, but shall be taken into account in
239 interpreting any positive confirmed test result.
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 10 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 12 97 (2020)
Amendment No. 1
240 (c) Specimen collection, storage, and transportation to a
241 laboratory the testing site shall be performed in a manner that
242 reasonably precludes contamination or adulteration of specimens.
243 (d) Each confirmation test conducted under this section,
244 not including the taking or collecting of a specimen to be
245 tested, shall be conducted by a licensed or certified laboratory
246 as described in subsection J.!Ql -t9+.
247 (e) A specimen for a drug test may be taken or collected
248 by any person who meets the qualification standards for urine or
249 oral fluid specimen collection as specified by the United States
250 Department of Health and Human Services or the United States
251 Department of Transportation. For alcohol testing, a person must
2 meet the United States Department of Transportation standards
253 for a screening test technician or a breath alcohol technician.
254 A hair specimen may be collected and packaged by a person who
255 has been trained and certified by a drug-testing laboratory. A
256 person who directly supervises an employee subject to testing
257 may not serve as the specimen collector for that employee unless
258 there is no other qualified specimen collector available of the
259 following persons:
260 1. A physician, a physician assistant, a registered
261 professional nurse, a licensed practical nurse, or a nurse
262 practitioner or a certified paramedic who is present at the
263 scene of an accident for the purpose of rendering emergency
264 medical service or treatment.
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 11 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
265 2. A qualified person CR'lployed by a licensed or certified
266 laboratory as described in subsection (9).
267 (f) A person who collects or takes a specimen for a drug
268 test shall collect an amount sufficient for two independent drug
269 tests, one to screen the specimen and one for confirmation of
270 the screening test results, at a laboratory as determined by the
271 Agency for Health Care Administration.
272 (g) Every specimen that produces a positive, confirmed
273 test result shall be preserved by the licensed or certified
274 laboratory that conducted the confirmation test for a period of
275 at least 1 year after the confirmation test was conducted -2-±-8-
276 days after the result of the test was R'lailed or otherwise
7 delivered to the R'ledical review officer. However, if an employee
278 or job applicant undertakes an administrative or legal challenge
279 to the test result, the employee or job applicant shall notify
280 the laboratory and the sample shall be retained by the
281 laboratory until the case or administrative appeal is settled.
282 During the 60-day 180 day period after written notification of a
283 positive test result, the employee or job applicant who has
284 provided the specimen shall be permitted by the employer to have
285 a portion of the specimen retested, at the employee's or job
286 applicant's expense, at another laboratory, licensed and
287 approved by the Agency for Health Care Administration, chosen by
288 the employee or job applicant. The second laboratory must test
289 the specimen at the limit of detection for the drug or analyte
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 12 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
290 confirmed by the original at equal or greater sensitivity for
291 the drug in question as the first laboratory. If the drug or
292 analyte is detected by the second laboratory, the result must be
293 reported as reconfirmed positive. The first laboratory that
294 performed the test for the employer is responsible for the
295 transfer of the portion of the specimen to be retested, and for
296 the integrity of the chain of custody during such transfer.
297 (h) Within 5 working days after receipt of a positive
298 verified,confirmed test result from the medical review officer,
299 an employer shall inform an employee or job applicant in writing
300 of such positive test result, the consequences of such result
301 results, and the options available to the employee or job
2 applicant. The employer shall provide to the employee or job
303 applicant, upon request, a copy of the test results.
304 ( j) The employee's or job applicant's e}{planation or
305 challenge of the positive test result is unsatisfactory to the
306 employer, a written explanation as to why the employee's or job
307 applicant's explanation is unsatisfactory, along with the report
308 of positive result, shall be provided by the employer to the
309 employee or job applicant; and All 5-U-eft documentation of a
310 positive test shall be kept confidential by the employer
311 pursuant to subsection (8) and shall be retained by the employer
312 for at least 1 year.
313 (k) An employer may not discharge, discipline, refuse to
314 hire, discriminate against, or request or require rehabilitation
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 13 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
315 of an employee or job applicant on the sole basis of a positive
316 test result that has not been reviewed and verified by a
317 confirmation test and by a medical review officer, except when a
318 confirmed positive breath alcohol test was conducted in
319 accordance with United States Department of Transportation
320 alcohol testing procedures.
321 (1) An employer that performs drug testing or specimen
322 collection shall use chain-of-custody procedures established by
323 the Agency for Health Care Administration, the United States
324 Department of Health and Human Services, or the United States
325 Department of Transportation to ensure proper recordkeeping,
326 handling, labeling, and identification of all specimens tested.
7 (6) CONFIRMATION TESTING.-
328 (a) If an initial drug test is negative, the employer may
329 in its sole discretion seek a confirmation test.
330 (b) Only licensed or certified laboratories as described
331 in subsection (9) may conduct confirmation drug tests.
332 -+et All laboratory positive initial tests on a urine, oral
333 fluid, blood, or hair specimen shall be confirmed using gas
334 chromatography/mass spectrometry (GC/MS) or an equivalent or
335 more accurate scientifically accepted method approved by the
336 United States Department of Health and Human Services or the
337 United States Department of Transportation Agency for Health
338 Care Administration or the United States Food and Drug
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 14 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
339 Adffiinistration as such technology becoffies available in a cost
340 effective forffi.
341 J..!21+:i+ If~ an initial drug test of an employee or job
342 applicant is confirmed by the laboratory as positive, the
343 employer's medical review officer shall provide technical
344 assistance to the employer and to the employee or job applicant
345 for the purpose of interpreting the test result to determine
346 whether the result could have been caused by prescription or
347 nonprescription medication taken by the employee or job
348 applicant.
349 (c) For a breath alcohol test, an initial positive result
350 must be confirmed by a second breath specimen taken and tested
1 using an evidential breath testing device listed on the
352 conforming products list issued by the National Highway Traffic
353 Safety Administration and conducted in accordance with United
354 States Department of Transportation alcohol testing procedures
355 authorized under 49 C.F.R. part 40, subparts J through M.
356 (7) EMPLOYER PROTECTION.-
357 (a) An employee or job applicant whose drug test result is
358 confirmed or verified as positive in accordance with this
359 section shall not, by virtue of the result alone, be deemed to
360 have a "handicap" or "disability" as defined under federal,
361 state, or local handicap and disability discrimination laws.
362 (9) DRUG-TESTING STANDARDS; SAMPLE VALIDITY PRESCREENING.-
363 Before a drug-testing facility licensed under part II of chapter
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 15 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
364 408 may perform any drug screening test on a urine specimen
365 collected in this state, prescreening tests must be performed to
366 determine the validity of the specimen. The prescreening tests
367 must be capable of detecting, or detecting and defeating, novel
368 or emerging urine drug-testing subversion technologies as
369 described in this subsection.
370 (a) The drug-testing facility shall use urine sample
371 validity screening tests that meet all of the following
372 criteria:
373 1. A urine sample validity screening test for creatinine
374 must use a 20 mg/dL cutoff concentration and must have minimal
375 interferences from bilirubin and blood in the urine. The urine
6 sample validity screening test must be able to discriminate
377 between a creatinine level from an unadulterated urine sample
378 and a creatinine level arising from overhydration or creatine or
379 protein loading.
380 2. A urine sample validity screening test for oxidants
381 must be able to detect the presence or effects of oxidant
382 adulterants up to 6 days after sample collection, under the
383 sample storage conditions outlined in the laboratory standards
384 guideline adopted by rule by the Agency for Health Care
385 Administration, and after any sample transport that is routinely
386 involved.
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 16 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
387 3. Urine sample validity screening tests must be able to
388 detect synthetic or freeze-dried urine substituted for the
389 donor's urine for drug testing.
390 4. Urine sample validity screening tests must be validated
391 for the detection of all of the additional adulterant classes
392 represented by glutaraldehyde, salt, heavy metals, cationic
393 detergents, protease, strong alkaline buffers, and strong acidic
394 buffers. The detection limits of these classes must be at a
395 sufficient level to detect a nonphysiologic sample or
396 interference with enzyme immunoassay drug-screening tests.
397 (b) The drug-testing facility may use only urine sample
398 validity screening tests that have undergone validation studies
9 conducted by the manufacturer to document the product's
400 conformance to the requirements of this subsection.
401 (c) A drug-testing facility may rely on urine sample
402 validity screening tests to determine if confirmation testing is
403 required for any urine sample that has been deemed invalid for
404 drug screening.
405 (d) Urine specimens collected in this state may not be
406 sent for drug-screening tests to a drug-testing facility located
407 outside of this state unless such drug-testing facility complies
408 with all requirements of this subsection.
409 (e) The Agency for Health Care Administration shall adopt
410 rules necessary for the implementation and enforcement of this
411 subsection.
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 17 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
412 llQl_-f--9+ DRUG-TESTING STANDARDS FOR LABORATORIES.-
413 (b) A laboratory may analyze initial or confirmation test
414 specimens only if:
415 1. The laboratory obtains a license under part II of
416 chapter 408 ands. 112.0455(18) s. 112.0455(17). Each applicant
417 for licensure and each licensee must comply with all
418 requirements of this section, part II of chapter 408, and
419 applicable rules.
420 2. The laboratory has written procedures to ensure the
421 chain of custody.
422 3. The laboratory follows proper quality control
423 procedures, including, but not limited to:
~4 a. The use of internal quality controls, including the use
425 of samples of known concentrations which are used to check the
426 performance and calibration of testing equipment, and periodic
427 use of blind samples for overall accuracy.
428 b. An internal review and certification process for drug
429 test results, conducted by a person qualified to perform that
430 function in the testing laboratory.
431 c. Security measures implemented by the testing laboratory
432 to preclude adulteration of specimens and drug test results.
433 d. Other necessary and proper actions taken to ensure
434 reliable and accurate drug test results.
435 (c) A laboratory shall disclose to the medical review
436 officer a written positive confirmed test result report within 7
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 18 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
437 working days after receipt of the sample. All laboratory reports
438 of a drug test result must, at a minimum, state:
439 1. The name and address of the laboratory that performed
440 the test and the positive identification of the person tested.
441 2. Positive results on confirmation tests only, or
442 negative results, as applicable.
443 3. A list of the drugs for which the drug analyses were
444 conducted.
445 4. The type of tests conducted for both initial tests and
446 confirmation tests and the minimum cutoff levels of the tests.
447 5. Any correlation between medication reported by the
448 employee or job applicant pursuant to subparagraph (5) (b)2. and
9 a positive confirmed drug test result.
450
451 A report must not disclose the presence or absence of any drug
452 other than a specific drug and its metabolites listed pursuant
453 to this section.
454 Section 3. Paragraph (b) of subsection (11) of section
455 443.101, Florida Statutes, is amended to read:
456 443.101 Disqualification for benefits.-An individual shall
457 be disqualified for benefits:
458 (11) If an individual is discharged from employment for
459 drug use as evidenced by a positive, confirmed drug test as
460 provided in paragraph (1) (d), or is rejected for offered
461 employment because of a positive, confirmed drug test as
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 19 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
462 provided in paragraph ( 2) ( c) , test results and chain of custody
463 documentation provided to the employer by a licensed and
464 approved drug-testing laboratory is self-authenticating and
465 admissible in reemployment assistance hearings, and such
466 evidence creates a rebuttable presumption that the individual
467 used, or was using, controlled substances, subject to the
468 following conditions:
469 (b) Only laboratories licensed and approved as provided in
470 s. 440.102(10) o. 440.102(9), or as provided by equivalent or
471 more stringent licensing requirements established by federal law
472 or regulation may perform the drug tests.
473 Section 4. This act shall take effect July 1, 2020.
'4
475
476 T I T L E A ME N D ME N T
477 Remove everything before the enacting clause and insert:
478 A bill to be entitled
479 An act relating to drug-free workplaces; amending s.
480 112.0455, F.S.; requiring licensed drug-testing
481 facilities to perform prescreening tests on urine
482 specimens to determine the specimens' validity;
483 specifying requirements for such tests; authorizing
484 such facilities to rely on such tests to determine if
485 confirmation testing is required; providing that urine
486 specimens may not be sent to an out-of-state facility
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 20 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
487 unless the facility complies with certain
488 requirements; authorizing the Agency for Health Care
489 Administration to adopt rules; conforming cross-
490 references; amending s. 440.102, F.S.; revising
491 definitions; revising information required in a
4 92 written policy statement provided to employees and job
493 applicants before drug testing; revising procedures
494 for specimen collection, testing, and preservation;
495 revising qualifications for persons who may take or
496 collect specimens for a drug test; revising
497 requirements and procedures for retesting specimens;
4 98 deleting and revising confidentiality requirements for
J9 employers relating to certain information; revising
500 circumstances under which an employer may take certain
501 actions as to an employee or a job applicant on the
502 sole basis of certain positive test results; revising
503 standards for chain-of-custody procedures; revising
504 requirements and authorized actions relating to
505 confirmation testing; requiring licensed drug-testing
506 facilities to perform prescreening tests on urine
507 specimens to determine the specimens' validity;
508 specifying requirements for such tests; authorizing
509 such facilities to rely on such tests to determine if
510 confirmation testing is required; providing that urine
511 specimens may not be sent to an out-of-state facility
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 21 of 22
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1297 (2020)
Amendment No. 1
512 unless the facility complies with certain
513 requirements; authorizing the agency to adopt rules;
514 conforming provisions to changes made by the act;
515 amending s. 443.101, F.S.; conforming a cross-
516 reference; providing an effective date.
517
518 WHEREAS, the State of Florida has a profound interest in
519 the health and welfare of its citizens, and
520 WHEREAS, new and emerging drug-testing subversion
521 technologies represent a significant threat to the ability to
522 properly identify those suffering from addiction and drug abuse,
523 and
.4 WHEREAS, the Legislature, therefore, seeks to require urine
525 sample validity testing, such that those persons being tested
526 can be properly and promptly identified for referral to drug
527 treatment programs and other health care services, NOW,
528 THEREFORE,
529
264657 - h1297-strike.docx
Published On: 2/3/2020 3:41:57 PM
Page 22 of 22
~ Il llllllliil~IIIIIIIIIIIIIIII Il
43214518
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
~ Bill D Amendment
Bill Number: HB 1139 : Regional Rural
Development Grants
Amendment Barcode Number: NIA
Name: Fausel, Natalie
Representing: Palm Beach County
Title:
Address: 201 W Park Avenue, Suite 100
City: Tallahassee State/Zip: FL
Phone Number: (561) 317-0889 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: NIA
~ Registered Lobbyist Bill
D State Employee Waive In Support
D I Wish To Speak Amendment
D Appearing in response to subpoena _ _ _ _ _ _ _ _ _~
~N_/A
D Appearing in response to an inquiry for information made by member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
~ Lobbyist Appearance Form Submitted
H-116e (Revised 1/17/2019)
Ill 1111111111111111111111111111111
66853085
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
~ Bill D Amendment
Bill Number: 1139 : Regional Rural
Development Grants
Amendment: NIA
Name: Tiffany Garling
Representing: Jackson County Chamber of Commerce
Title:
Address: 4318 Lafayette Street
City: Marianna State/Zip: FL 32446
Phone Number: 8504828060 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: NIA
D Registered Lobbyist Bill
D State Employee Waive In Support
DI Wish To Speak Amendment
D Appearing in response to subpoena .__N_IA
_ _ _ _ _ _ _ _ ___.
D Appearing in response to an inquiry for information made by member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted
H-l6e (Revised 10/21/16)
1111111111111111111111111111 IIIIII
76179400
~
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
~ Bill D Amendment
Bill Number: 1139 : Regional Rural
Development Grants
Amendment: NIA
Name: Darrick McGhee, Sr.
Representing: Florida's Great Northwest
Title:
Address: Po Box 10805
City: Tallahassee State/Zip: FL
Phone Number: (850) 224-1900 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: NIA
~ Registered Lobbyist Bill
D State Employee Waive In Support
DI Wish To Speak Amendment
D Appearing in response to subpoena . . .N_I_A_ _ _ _ _ _ _ ___,
D Appearing in response to an inquiry for information made by member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
~ Lobbyist Appearance Form Submitted
H- l 6e (Revised 10/21/16)
~ ~,,JI 11111111111111!111111111111111
36922034
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
~ Bill D Amendment
Bill Number: HB 1139 : Regional Rural
Development Grants
Amendment Barcode Number: NIA
Name: Williams, Richard
Representing: Opportunity Florida
Title: Executive Director
Address: 4636 Highway 90 East, Suite K
City: Marianna State/Zip: Fl32446
Phone Number: 850-557-2441 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: NIA
D Registered Lobbyist Bill
D State Employee Waive In Support
DI Wish To Speak Amendment
D Appearing in response to subpoena L,.N_I_A_ _ _ _ _ _ _ _ __J
D Appearing in response to an inquiry for information made by member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted
H-116e(Revised 1/17/2019)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill~ Amendment D
Bill/PCS/PCB Number: \ 8°/
Amendment Barcode Number: - - - - - - -
Name: CO.VO\~ i:JbYBSCC)
'Y1
Representing: __ ==
- ~ ~-......--~-___,'--'--'-_._.......,.,"-"--=--------------
,_(.....--"--~-=--___.-=---=--"--....
Title: f?Du~ -:D·,y~
Address: D\.O s ~ n ~~
City:]~~ State/Zip:~~~~~~~~~
Phone Number: ~ - l ov"D
-----~--------- ........_4__._\
Meeting Date:_~_ } _2o
___
Committee/Subcommittee: ~.fo'((_Q_ 3).el ~met*:: ~ ~Ll..9.-,VllfV)
Presentation/Workshop Topic: "2u..vm ~ ~VQ..Vt\- 5
Registered Lobbyist: YES ~
State Employee: YESD
~wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: Proponent ifopponent D Waive in Support D Waive in Opposition D Info only D
Amendment: ProponentO OpponentO Waive in SupportD Waive in OppositionO Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill Amendment D
Bill/PCS/PCB Number: --+/-+/_:S_C/_,__
I I
__
rcode Number: - - - - - -
Name: ~///}
£L (-'.q / vY1 & t" (' ':!y'-1
Representing:
Title:
Address:
f1-- ltf!/"5k--f-/vc_
3 1a w Cd l-e5
z~~,V}
I < ~.--c, .
City: -r; I~ LC s· ~. State/Zip: ?L 523o}
Phone Number: -;2 J. L 2 ~S7 Meeting Date: '-- ) / // / .:;zfJ
7' /qf
Committee/Subcommittee: U&kYJLc0
Presentation/Workshop Topic: --ll--....>.<..:..r.....=L-f---~-::'r....:;__c.._;_n.....,...·f'--f-------------
Registered Lobbyist: YES
NOD/
State Employee: vEsD NO~
~speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proP, nt or opponent on the bill as a whole.)
Bill: D Opponent D Waive in Support Waive in Opposition D Info only D
Proponent
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill [i:] Amendment D
Bill/PCS/PCB Number: _I\_3_°1....;..__ _
Amendment Barcode Number: - - - - - -
Name: M·~~o&,_5 Alvq&zr
Representing: --D__.e_.,,j),.....a-~--~-¢--6'--f)
__fu~~n._o_tWJ_l~C:-----.tJ--+-A"-+fl._'t?r-___,~_~}h,___,f~-
Title: D-w~ ~ ~1.'1h~
Address: W7 E ~ ~r
City: fo(/U,?to~ State/Zip: FL, ) ~ J t/r
Phone Number: C£So,- ;}Ll~ -- 7170 Meeting Date: ~/ o/.J.-o
Committee/Subcommittee: Wo,....k~ ~ J - ~ ~r,'Y'"'1
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES ~
State Employee: YES fil
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: Proponent fill Opponent D Waive in Support [El Waive in Opposition D Info only D
Amendment: Proponent Ill Opponent D Waive in Support K) Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill E2f Amendment D
Bill/PCS/PCB Number: // J CJ
Amendment Barcode Number: - - - - - -
Name: _ _ 8,-............r_+_h_C_it._c_ck_~_+h_·_______________
Representing: _ c_+__~_-
__._F__.._v_'_.f'_l'(_-J_a-_ _.[;_~('"""·{l_v\_uv_"'_-1.._t_e_. . .J_e_··. .,__<-_(_w_)_,___,vt..a_...{,
1
__ _·_J_.
_._-__
Title: 1:+, E' C lf1' J e... b1 rec_ --4-r
-----'------------""'--------------------------
Address: 3 ~-s-
I i3 \c"- l·,) ~ ~ e I OS - \ 3 ~
-~--------------------'-~~------------- RJ +-
City: _1]
__ --'--ti--~_··_~5_·_
a{_· S-0--
_ _ _ _ __ State/Zip: PL- 3 L-- .> 0 I
- -(f~ -L
-2-/ ,.Q /'{J/ 1 0
Phone Number: i) /0~ Meeting Date:
-- ---------
Committee/Subcommittee: 'VJ-:,< k fuvCQ \Je__,/ ~ T-; u v S vv- t
Presentation/Workshop Topic: Re% <J:Y\c.f}_ 'R
j \..Af(_}... I be Ve lrti~ --r:V(Y--1?;.
Registered Lobbyist: YES ~
State Employee: vEsD
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: Proponent D Opponent D Waive in Support~ Waive in Opposition D Info only D
Amendment: ProponentO OpponentO Waive in SupportD Waive in OppositionO Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill~· Amendment D
Bill/PCS/PCB Number: {J-fJ I I"?;, 9
Amendment Barcode Number: - - - - - -
Name: A;.J7DV/l> .JE.,~StrJ
Representing: fl f?.v ~ {?C,orJ{)f.( (C/ f}{?I../ A..,...35';'L,
Title: 60 (\;~) M eA-J ,3e/Z.
Address:
---------------------------------
City: _ _____,,{f:"----'-U--=-i...--r,___;:;;,J_k_·_ _ _ _ _ __ State/Zip: r:;:;L
1___
Phone Number: _'p_____.;.~_'i:>_')_./'_l_._1----"D;...._b_</_' Meeting Date: 7.-. ·'{. '2o
Committee/Subcommittee: _Lv_o_K.J_L_n>_i£€
__· _1)_6.J
__ .. _17J_LJ_IC-t_.5_A1..___--"-7V----'-P--=v?-·~I(._·J{~.
.J--_._
Presentation/Workshop Topic: _/l6
__G_rr_o_0_A--=L:....___/Zu
__4_..;;._L_....::!)_t::_N_---=-6~
_ ___:,,__;_;-_·__
Registered Lobbyist: YES D NOW-
State Employee: vEsD NO~·
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: D Opponent D Waive in Support ~ a i v e in Opposition D Info only D
Proponent
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill ~ Amendment D
Bill/PCS/PCB Number: I l aq
Amendment Barcode Number: _ _ _ _ _ __
Name: _ ____;;;,C_h_Y'_i_s~=».,..c..J_v_o_lt·_V\..
_ _ _ _ _ _ _ _ _ _ _ _ _ __
Representing: 0 (Y\ A LL C tJ v(,NT'I CO A-L l Tl O f\J"
- -V\-0 -ut,-l~
- -(JC>
Title:
- - -Y
-------------------------
Address: l l l ~ ... B -rl-~CI\..-S
J 'L-Lt RJ·
Phone Number: 8-'0 - 5o 8" -G't/C/ Z--- Meeting Date: ?...- zf-- ?-0
Committee/Subcommittee: vv,vl'I< hV'(}..;?~e~ ~~VV\
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES cg.,// NO D
State Employee: vEsD
~htospeak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
{If you are testifying on an amendmrlease also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: Proponent [g"' Opponent D Waive in Support D Waive in Opposition D Info only D
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
Ill 1111111111111111111111111111111
10421876
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
[i] Bill D Amendment
Bill Number: NIA
Amendment: NIA
Name: Roy Baker
Representing: Jackson County Chamber of Commerce
Title:
Address: 4318 Lafayette St
City: Marianna State/Zip: FL32446
Phone Number: 850-482-8060 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: HB 1139 Regional Rural Development Grants
D Registered Lobbyist Bill
D State Employee Waive In Support
DI Wish To Speak Amendment
D Appearing in response to subpoena '-N_IA
________ __...J
D Appearing in response to an inquiry for information made by member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted
H-16e (Revised 10/21/16)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill g Amendment D
Bill/PCS/PCB Number: / / 39
Amendment Barcode Number: - - - - - - -
. .=..D_.
Name:_S_ _Jc_~J-~_r-_s-r___________
Representing: A-:ss¢<:.,1' Q r-e d
Title:
------------------------------------
Address: _5....::;__/_(p--L;(}____:::__--'-A_._d=-....;;_a;;.._vn-'-',5""---------------
City: fqJ/c>ha s~e State/Zip:~;::::2.~~~~~~~-
Phone Number: a.SO t/t:JJ 00.S- L Meeting Date: 2/'f/2'o2-o
Committee/Subcommittee: ____;;\A e_--=D--'w;;;.......;..-'-e_(o-+y,_lNJ_e_11_}_}-_fc.:.....t>=.......lN.....1......\c:...:"""--;..;:;;;__ __
} o-'-v_t<._{;,.,__Y_t.....
........
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES ~ NOD
State Employee: vEsD NO~
~ i s h to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
{If you are testifying on an amendment, please also indicate your position :_:7onent or opponent on the bill as a whole.)
Bill: D Opponent D Waive in Support ~ Waive in Opposition D Info only D
Proponent
Amendment: ProponentO OpponentO Waive in SupportO Waive in OppositionO Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill l.S<I Amendment D
Bil I/PCS/PCB Number: _J.-=-1.J__,'/'-----
Amendment Barcode Number: - - - - - -
Title:
Address:
----------------------------------
City:------------------- State/Zip: _ _ _ _ _ _ _ _~
Phone Number: -~~~5_cJ_-_i....__£_(.f_-_/~J0_}_ Meeting Date: ltlzo~o
..2I..
Committee/Subcommittee: S°0b · Ct>/H/11•./;T-ce
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES D NO~
State Employee: vEsD NOD
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: D Opponent D Waive in Support ~ Waive in Opposition D Info only D
Proponent
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill [a' Amendment D
Bill/PCS/PCB Number: _fi_'/3_1___
Amendment Barcode Number: - - - - - -
Name: LA::U~ YOUM ,+N .S
Representing: Pl,2tl.,1n A A-S:.{ O GL A:7 Io AJ OP C....OtJAJ 7 ( & S:
Title: l6C-·dSC41t V£ U> l.A..A.J r.:;:L
-l!1L
City: -"'--~..........a=------------------ State/Zip: /Z-l, /12,-3 U/
Phone Number: _l'-4_'L.f_-_/!_3_K
_ _ _ _ _ _ __ Meeting Date: _ _ _ _ _ _ __
Committee/Subcommittee: Wc.J'l.~pot.LZ; /4AfuU -4-1 ~ v,.,..J
Presentation/Workshop Topic: f..lt(2..AL ILGblt:9"14L i>4UGWAA ,;,.µT
Registered Lobbyist: YES ~ NO D
State Employee: YESD NO 8"'
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: Proponent ~pponent [J Waive in Support ~Waive in Opposition D Info only D
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bii,:.:[fi Amendment D
Bill/PCS/PCB ·~~r: _\_l._~_-7,;___
Amendment Barcode Number: - - - - - -
Name: t~ I vt+Q LA-{ fBlVftKE 7_
Representing: Df-IT 0--f f (~) i~ ()~1 \ l, ~f>.pe KTl~ f\J \T'(
Title:~ Dltzf=(iTo(Z OF Lf L71 J-1411\J t Af-Ffr \ KJ
Address: \ Ol t;· MA-0 I J.eJ N \JT
City: TA--vlrA++M s ~~ e State/Zip: :EL , 2>1.3 q9
Phone Number: gS O- L~ 5 · -1 ~ ·1,e) Meeting Date: L- · '.1 · 1,61,-0
Committee/Subcommittee: V\t'8'fK fO l(_l;f DfVfLVPf1fNTq)T(JL~ f21 }jv1
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES~
State Employee: YES~
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: D Waive in Support Q' Waive in Opposition D Info only D
ProponenfElJ Opponent
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill~ Amendment D
Bill/PCS/PCB Number: -'-\--'-1-_1______;_1_ __
Amendment Barcode Number: _ _ _ _ __
Name: _N_I\l---'1 -H-0_,___LAf-'---'-----_/j-L--'---'--\__.'A:~,Z--"-~-7_ _ _ _ _ _ __
Representing: Df PT Of f{AJNOM ( (1 OPPorzn~NIT1
Title: DHZt=-c,cJ K OF Lf (7( J-t A-Tl V (;, A-ff A-\ rZ_J
Address: \ 01 f- fv1A-i>I f'Gf~ ~
City: TA-\; L1:tt::tfu[ ~ f· ~- State/Zip: -FL 1 3 L3 °I c1
Phone Number: ~ 5-0 -1,1 5 '-11:>-l)J Meeting Date: l- · Li · l,V W
Committee/Subcommittee: \tJO~<'.._f- GfZC,,f- Dt; V- ~ l1Jv1 Y2'1 S'1VI
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES B
State Employee: YES 2Q
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
(If you are testifying on an amendment, please also indicate your position as a proponent or opponent on the bill as a whole.)
Bill: D Waive in Support fgj} Waive in Opposition D Info only D
Proponent~ Opponent
Amendment: Proponent D Opponent D Waive in Support D Waive in Opposition D Info only D
H-116 (2020)
/
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill D Amendment
Bill/PCS/PCB Number:-~/ -~_q_·7
___
Amendment Barcode Number: - - - - - -
Name: _~_13__,..·...
·o_·b_b_te_s_·L.t._G-_6-S
_ _ _ _ _ _ _ _ _ __
Representing: \jp)( i
Title: C.C--0
Address: ·7_ 0. T5DK soy
----------------------------------
City: )512- Ml { o-R-D L-L State/Zip: rL, '3zt:0P
Phone Number: ( ~~b) ~6'7 ,_ /0 ~3
---'-~<.- - ' - - - - - - - - - - - - Meeting Date: _ _ !(_~o
~-+--~-------
Committee/Subcommittee: v.Jo~ fv /2.C6-
-----''--------------------------
Presentation/Workshop Topic:
--------------------------
Registered Lobbyist: YES D NO§/
State Employee: vEsD NO Q""
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted online
(If you are testifying on an amendment, please also indicate your position as a /ponent or opponent on the bill as a whole.)
Bill: Proponent 0
D Waive in Support Q Waive in Opposition D Info only D
Opponent
Amendment: ProponentO OpponentO Waive in SupportO Waive in OppositionO Info only D
H-116 (2020)
111111111181111111111
68739866
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit two copies to the committee/subcommittee
--administrative assistant at the meeting.
~ Bill D Amendment
Bill Number: HB 1297: Drug-free Workplaces
Amendment Barcode Number: N/A
Name: Burress, Tabitha
Representing: Florida Cannabis Action Network
Title: Ms.
Address: 4320 Randall Blvd
City: Naples State/Zip: FL 34120
Phone Number: 2392722257 Meeting Date: February 04, 2020 9:00 AM
Committee/Subcommittee: Workforce Development & Tourism Subcommittee
Presentation/Workshop Topic: N/A
0 Registered Lobbyist Bill
0 State Employee Info Only
~ I Wish To Speak Amendment
D Appearing in response to subpoena ._N_/A
_ _ _ _ _ _ _ _____,
D Appearing in response to an inquiry for information made by member, committee or staff
0 Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted
H-116e (Revised 1/17/2019)
COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD
Please fill out the entire form and submit both copies to the Committee Administrative
Assistant at the meeting.
Bill 0 Amendment D
Bill/PCS/PCB Number: ) ~ 0, 3:
Amendment Barcode Number: - - - - - - -
Name: :e. _J YY) V,r-(2.5
Representing: $AV~ O\Ji2.. Soe-1 e'f'lt
Title: LP~ 151
Address: ) )~ f; Go~C,~
City:--:,::Pl.A..,.o~ State/Zip: f 1.,,/ ~;)3,c, J
I
Phone Number: \ ~ Jc:;3 3-o ctC" 3 Meeting Date: .:l. I '-t JJ.o
Committee/Subcommittee: Uc;?F, t.~i.t* ~y 'f ,'o.rr- "5t""""
I
Presentation/Workshop T o p i c : - - - - - - - - - - - - - - - - - - - - - - - - - -
Registered Lobbyist: YES 0
State Employee: vEsD
D I wish to speak
D Appearing in response to an inquiry for information made by member, committee, or staff
D Appearing in response to subpoena
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance form submitted on line
(If you are testifying on an amendment, please also indicate your position as 7oponent or opponent on the bill as a whole.)
Bill: D Opponent D Waive in Support 0 Waive in Opposition D Info only D
Proponent
Amendment: ProponentO OpponentO Waive in SupportO Waive in OppositionO Info only D
H-116 (2020)
File and source
- File
- 2020-02-04_3015_workforce-development-tourism-subcommittee_action-packets_mtg12599.pdf
- Size
- 1,434,614 bytes
- SHA-256
- 0ef862c847324ba315cf549fd7e73b2c8a73e752ff61b210317093430dbe7305
- Original
- No public link identified.